Race Oncology Ltd (ASX:RAC)’s stock price dropped 2.9% during mid-day trading on Monday . The company traded as low as A$0.34 ($0.24) and last traded at A$0.34 ($0.24), approximately 76,322 shares traded hands during trading. The stock had previously closed at A$0.35 ($0.25).
The company has a market cap of $39.30 million and a price-to-earnings ratio of -9.71. The business’s 50 day simple moving average is A$0.31 and its 200-day simple moving average is A$0.26.
About Race Oncology (ASX:RAC)
Race Oncology Limited operates as a specialty pharmaceutical company in Australia. It develops Bisantrene, a small molecule cancer chemotherapy drug that is used for the treatment of acute myeloid leukaemia. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016.
Read More: Retained Earnings
Receive News & Ratings for Race Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Race Oncology and related companies with MarketBeat.com's FREE daily email newsletter.